Investing in the future of life science
Novo A/S spans the entire range of life science investments: from early-stage ideas that need financial and commercial nurturing, to well-established biomedical and bioindustrial companies that require significant capital and a long-term investor to accelerate growth.
We are able to provide the managerial, financial and strategic support that companies need to develop to the next stage, and we have the financial strength to stay the course.
Novo plans to significantly grow its large investments and venture portfolio in the years to come.
Adding value to society
Novo will remain a strong owner of the companies in the Novo Group. In accordance with the Articles of Association of the Novo Nordisk Foundation, Novo has a permanent commitment to remain the controlling shareholder in Novo Nordisk and Novozymes.
On the investment front, Novo will deploy its capital in the life science sector to generate attractive returns that will enable the Foundation to continue to increase its grants for scientific, humanitarian and social purposes.